These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1360855)
41. Salmeterol administration by metered-dose inhaler alone vs metered-dose inhaler plus valved holding chamber. Demirkan K; Tolley E; Mastin T; Soberman J; Burbeck J; Self T Chest; 2000 May; 117(5):1314-8. PubMed ID: 10807816 [TBL] [Abstract][Full Text] [Related]
42. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003 [TBL] [Abstract][Full Text] [Related]
43. Bronchodilation subsensitivity to salbutamol after salmeterol. Barnes N Lancet; 1995 Oct; 346(8980):968; author reply 968-9. PubMed ID: 7564751 [No Abstract] [Full Text] [Related]
44. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol. Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526 [TBL] [Abstract][Full Text] [Related]
45. Protection against allergen-induced asthma by salmeterol. Twentyman OP; Finnerty JP; Harris A; Palmer J; Holgate ST Lancet; 1990 Dec; 336(8727):1338-42. PubMed ID: 1978163 [TBL] [Abstract][Full Text] [Related]
46. Bronchodilation subsensitivity to salbutamol after salmeterol. Ng HW Lancet; 1995 Oct; 346(8980):968; author reply 968-9. PubMed ID: 7564752 [No Abstract] [Full Text] [Related]
47. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction. Solèr M; Joos L; Bolliger CT; Elsasser S; Perruchoud AP Eur Respir J; 1994 Nov; 7(11):1973-7. PubMed ID: 7875267 [TBL] [Abstract][Full Text] [Related]
48. Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours. Nowak D; Jörres R; Rabe KF; Lüthke M; Wiessmann J; Magnussen H Eur J Clin Pharmacol; 1992; 43(6):591-5. PubMed ID: 1493839 [TBL] [Abstract][Full Text] [Related]
49. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma. Harrison LI; Novak CC; Needham MJ; Ratner P J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):245-52. PubMed ID: 21671752 [TBL] [Abstract][Full Text] [Related]
50. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143 [TBL] [Abstract][Full Text] [Related]
51. A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction. Beach JR; Young CL; Stenton SC; Avery AJ; Walters EH; Hendrick DJ Pulm Pharmacol; 1992 Jun; 5(2):133-5. PubMed ID: 1611231 [TBL] [Abstract][Full Text] [Related]
52. Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol. Lipworth BJ; Jackson CM Chest; 2002 Apr; 121(4):1382. PubMed ID: 11948092 [No Abstract] [Full Text] [Related]
53. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment. Nelson HS; Wolfe JD; Gross G; Greos LS; Baitinger L; Scott C; Dorinsky P Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658 [TBL] [Abstract][Full Text] [Related]
54. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Carlsen KH; Røksund O; Olsholt K; Njå F; Leegaard J; Bratten G Eur Respir J; 1995 Nov; 8(11):1852-5. PubMed ID: 8620951 [TBL] [Abstract][Full Text] [Related]
56. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Grove A; Lipworth BJ Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798 [TBL] [Abstract][Full Text] [Related]
57. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma. Bateman ED; Silins V; Bogolubov M Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910 [TBL] [Abstract][Full Text] [Related]
58. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate. Mahler DA; Waterman LA; Ward J; Gifford AH J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526 [TBL] [Abstract][Full Text] [Related]
59. Paradoxical bronchoconstriction and salmeterol. Wilkinson JR BMJ; 1992 Dec; 305(6867):1502. PubMed ID: 1362915 [No Abstract] [Full Text] [Related]